1.How to avoid stepping on the pit? Expert: Be sure to pay attention to these details
Recently, the violation of using “makeup brand” cosmetics for facial beauty injections has been exposed by the media. How can beauty lovers maintain calm and sobriety during the beauty treatment process, eliminate false and retain true, and safely become beautiful? Recently, plastic and cosmetic surgeons at Beijing Union Medical College Hospital proposed “avoiding the pit” to the public.
Can licensed physicians conduct medical aesthetic treatment?
Practicing medicine without a license is undoubtedly the “pit” that people are most worried about when conducting medical aesthetic treatment. But can doctors with professional medical qualifications carry out medical aesthetic treatment with great strides?
The answer is no, not that practicing physicians are allowed to practice surgery for beauty.
Xiao Yiding, the attending physician of plastic and aesthetic surgery at Beijing Union Medical College Hospital, introduced that only doctors with the qualification of “medical and aesthetic attending physician” can preside over medical and aesthetic related operations, operations, and even diagnosis and treatment. There are strict application conditions for the qualification of a medical beauty attending physician. Medical beauty attending physicians engaged in cosmetic surgery need to meet the requirements of having worked in the field of plastic and aesthetic surgery for at least 6 years; The scope of medical practice can also be queried on the corresponding website of the National Health Commission.
The doctor reminded that some organizations will make false publicity on the doctor’s title, or share the preoperative and postoperative comparison pictures through PS on the website and official account, which is not recommended for reference.
Is there a batch number of medical devices that are compliant?
Xiao Yiding introduced that each medical device has corresponding indications at the time of approval, including the level and location of injection. For example, bone cement is one of the commonly used repair materials in clinical applications, mainly used for filling and repairing various bone defects. However, under the hype of some institutions, some unknown beauty seekers have received intrascalp injections of bone cement in an attempt to improve the appearance of the skull, ultimately resulting in scalp necrosis due to excessive tension after injection.
So, how do you choose medical beauty institutions and medical beauty projects to be safe and reliable? Xiao Yiding made three suggestions.
First, compare goods with three hospitals or institutions, go to multiple hospitals or institutions for medical treatment, listen to the suggestions of all parties, and then make a comprehensive decision. In particular, regular hospitals pay more attention to the departments and doctors who rank among the top in the national plastic surgery field on the official rankings. Although clinical surgical resources are scarce, they have rich experience and pertinent recommendations, which are highly worth consulting first.
Secondly, to search for certificates online, it is recommended to mainly search for two points: first, go to the “National Medical Institution Query” website to search whether the target medical and aesthetic institution is formal, and then search for the practicing scope and academic achievements of the attending physician.
Third, enrich yourself, watch more medical and aesthetic popular science programs released by well-known doctors and popular science scholars in major hospitals, store relevant knowledge before face-to-face visits, and minimize information gaps with the attending physician to achieve more thorough communication and consultation.
2.Improved access to multiple prostate cancer drugs and other advanced prostate cancer patients benefit from precision treatment
With the aging of China’s population, the incidence rate and mortality of prostate cancer are on the rise, which is one of the important threats to men’s health.
Ye Dingwei, Vice President of the Cancer Hospital Affiliated to Fudan University, said in an interview on the 10th: “The rapid progress of China’s aging population is an important reason for the increasing incidence rate and mortality of prostate cancer, and the future burden should not be underestimated. At the same time, the early symptoms of prostate cancer are relatively hidden, and many patients are often difficult to detect, and once there are obvious symptoms, they are usually in the late stage, which leads to the majority of initial cases of prostate cancer in China in the middle and late clinical stages, and the overall prognosis of patients is poor.”
In recent years, thanks to the progress and development of prostate cancer diagnosis and treatment technology in urology, the five-year survival rate of prostate cancer patients in China has been improved to some extent, but there is still a gap compared to the five-year survival rate of developed countries (regions). It is understood that due to reasons such as atypical early symptoms of prostate cancer, many prostate cancer patients in China have advanced or locally advanced or distant metastasis at the initial diagnosis.
“Implementing the concept of early detection, early diagnosis, and early treatment is the key to catching up with this gap. In clinical practice, testing prostate specific antigen (PSA) through blood sampling is the simplest method for screening prostate cancer, helping to improve the detection rate of prostate cancer and helping patients detect and treat it early.” Xue Wei, deputy director of Renji Hospital affiliated to Shanghai Jiaotong University Medical College, said.
It is reported that the survival time of patients with prostate cancer is closely related to the stage of malignant tumor at the time of clinical diagnosis. Metastatic castration resistant prostate cancer (mCRP C) is the terminal stage of prostate cancer, and it is also a difficult point in the treatment of prostate cancer. In mCRP C patients, up to 30% of patients have related gene mutations, with BRCA1/2 gene mutations being the most common. Lin Tianxin, deputy dean of Sun Yixian Memorial Hospital and professor of urology at Sun Yat-sen University, said that such patients urgently need more professional management methods, modern means, and more innovative drugs to promote precise targeted treatment and help patients obtain better clinical benefits.
It is reported that a number of prostate cancer drugs and new indications, including digitalic acetate for injection, apatamide tablets, darotamide tablets, and PARP inhibitor olaparide, have been included in the national medical insurance drug catalog. This will further meet the drug needs of patients with advanced prostate cancer, help more patients with advanced prostate cancer use high-quality and affordable innovative drugs, and will also promote the treatment of prostate cancer to the international mainstream drug level.
Ye Dingwei said, “There is a long way to go in the prevention and treatment of prostate cancer. The introduction of innovative drugs, including precision targeted therapeutic drugs, into medical insurance will accelerate the realization of patients’ availability of drugs and access to good drugs, enabling more patients and patient families to benefit from innovative clinical treatment achievements. At the same time, because of the relatively high efficacy of precision therapy, it is also conducive to the effective use of the National Medical Insurance Fund.”
JinDun Medical has long-term scientific research cooperation and technology grafting with Chinese universities. With Jiangsu’s rich medical resources, it has long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets. It also provides market and sales services in the whole process from intermediate to finished product API. Utilize the accumulated resources of Yangshi Chemical in fluorine chemistry to provide special chemical customization services for partners. Provide process innovation and impurity research services to target customers.
JinDun Medical insists on creating a team with dreams, making products with dignity, meticulous, rigorous, and go all out to be a trusted partner and friend of customers!One stop solution providers, customized R&D and customized production services for pharmaceutical intermediates and APIs, professional customized pharmaceutical production (CMO) and customized pharmaceutical R&D and production (CDMO) service providers.
Post time: Apr-07-2023